The survival analysis revealed that ESR1 and RELA together with the hub genes including EGFR, PIK3CA, MYC, and SMAD3 were proved to have prognostic value on NSCLC patients’ survival. This evidence concerns the gene MYC and non-small cell lung carcinoma.